Álvaro Herrero-Navarro

Álvaro Herrero-Navarro

Auto-generated profile, based on publicly available information

Álvaro Herrero-Navarro

Institute of Molecular and Clinical Ophthalmology Basel, Basel, Switzerland

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 April 2021 in Science Advances
Verified
Journal Article
Open access
PDF file
ÁHÁlvaro Herrero-Navarro
Álvaro Herrero-Navarro
LPLorenzo Puche-Aroca
Lorenzo Puche-Aroca
VMVerónica Moreno-Juan
Verónica Moreno-Juan
ASAlejandro Sempere-Ferràndez
Alejandro Sempere-Ferràndez
AEAna Espinosa
Ana Espinosa
GLGuillermina López-Bendito
Guillermina López-Bendito
Region-specific gene expression shared with neurons imparts to astrocytes competence for region-specific neuronal reprogramming.

15 April 2026 in Nature
Verified
Journal Article
Open access
PDF file
TATemurkhan Ayupov
Temurkhan Ayupov
VMVerónica Moreno-Juan
Verónica Moreno-Juan
SCSerena Curtoni
Serena Curtoni
AFAlex Fratzl
Alex Fratzl
USUpnishad Sharma
Upnishad Sharma
BRBotond Roska
Botond Roska
A number of currently untreatable diseases, including neurodegenerative disorders, optic nerve atrophy and heart failure, are associated with mitochondrial dysfunction. Transplantation of healthy mitochondria has been proposed as a potential therapeutic strategy1,2,3. However, the lack of methods to target donor mitochondria to disease-affected cell types limits treatment specificity and efficacy. Here we developed MitoCatch as a system to deliver mitochondria to specific cell types using different types of protein binders. Donor mitochondria are captured by target cells by cell-surface-displayed monospecific binders, mitochondrion-displayed monospecific binders or bispecific binders linking mitochondria to target cells. Using MitoCatch, we show that donor mitochondria are efficiently internalized, exposed to the cytosol, move, and undergo fusion and fission inside target cells. By engineering binders with different affinities, we tune the efficiency of mitochondrial delivery. We demonstrate targeted mitochondrial transplantation to retinal cell types, neurons and cardiac, endothelial and immune cells in humans and mice. Transplanted mitochondria promoted the survival of damaged neurons from an individual with optic nerve atrophy in vitro and after neuronal injury in mice in vivo. MitoCatch is a potential strategy to target disease-affected cell types with mitochondria in organs affected by diseases associated with mitochondrial dysfunction.

5 November 2023 in IBRO Neuroscience Reports
Verified
Journal Article
Open access
SFSofia Ferreira
Sofia Ferreira
JMJoana M. Marques
Joana M. Marques
ÁHÁlvaro Herrero-Navarro
Álvaro Herrero-Navarro
SASofia Alçada-Morais
Sofia Alçada-Morais
ELEduardo Leyva-Diaz
Eduardo Leyva-Diaz
Ricardo J RodriguesRicardo J Rodrigues
Ricardo J Rodrigues